Kate Falberg

Board Member
immunology
Eurogen
Ecuador

Business Expert Immunology
Biography

Kate Falberg has served as our director since April 2017.  Ms. Falberg has held several CFO and Head of Strategy and Corporate Development roles in the technology and biotechnology industries including for Applied Magnetics, Amgen and, most recently, Jazz Pharmaceuticals.  She also currently serves on the boards of, Aimmune Therapeutics, aTyr Pharma, Axovant Sciences, BioMarin Pharmaceutical and The Trade Desk, and formerly served on multiple boards including Medivation and Halozyme Therapeutics.  Ms. Falberg holds a B.A. and M.B.A from UCLA, is a CPA, inactive, and a UCLA Certified Director.

Research Intrest

Kate Falberg has served as our director since April 2017.  Ms. Falberg has held several CFO and Head of Strategy and Corporate Development roles in the technology and biotechnology industries including for Applied Magnetics, Amgen and, most recently, Jazz Pharmaceuticals.  She also currently serves on the boards of, Aimmune Therapeutics, aTyr Pharma, Axovant Sciences, BioMarin Pharmaceutical and The Trade Desk, and formerly served on multiple boards including Medivation and Halozyme Therapeutics.  Ms. Falberg holds a B.A. and M.B.A from UCLA, is a CPA, inactive, and a UCLA Certified Director.